Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique (NECPAR)
Primary Purpose
Nephrectomy, Kidney Cancer, Microdialysis
Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Renal microdialysis
Sponsored by
About this trial
This is an interventional other trial for Nephrectomy focused on measuring parenchymal clamping, microdialysis technique, partial nephrectomy
Eligibility Criteria
Inclusion Criteria:
- Patients referred to the urological surgery department with an indication of partial nephrectomy
- Patients with a renal lesion classified T1 (≤7cm) or for T2 eligible to a partial nephrectomy and having an possibility to benefit from a parenchymal clamping (decided on preoperative imaging)
Exclusion Criteria:
- Patient with a chronic kidney disease (functional or structural renal abnormality evolving for more than three months and Glomerular Filtration Rate <60 ml/min)
- Patient carrying a renal lesion classified T1 but too close to the renal pedicle or not accessible for a parenchymal clamping
- Patients in whom tumor removal requires ice cooling or kidney pedicular clamping
Sites / Locations
- Chu de Saint Etienne
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
renal microdialysis
Arm Description
patient with renal microdialysis
Outcomes
Primary Outcome Measures
Average interstitial lactate concentrations (peak lactate and lactate/pyruvate ratio)
Secondary Outcome Measures
Interstitial concentrations of lactate, pyruvate, lactate/pyruvate ratio, glycerol concentration (marker of impaired cellular membrane) and glucose concentration
composite measure
Blood and urine concentration of Interleukin 18 (IL18), le Kidney Injury Molecule-1 (KIM-1), le Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin C
composite measure
Preoperative creatinine
Full Information
NCT ID
NCT02511275
First Posted
February 20, 2015
Last Updated
May 3, 2018
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
University Hospital of Saint-Etienne
1. Study Identification
Unique Protocol Identification Number
NCT02511275
Brief Title
Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique
Acronym
NECPAR
Official Title
Assessment of Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique: NECPAR Study
Study Type
Interventional
2. Study Status
Record Verification Date
May 2018
Overall Recruitment Status
Terminated
Why Stopped
this type of surgery is now performed with a surgical robot that no longer allows the realization of microdialysis
Study Start Date
February 3, 2015 (Actual)
Primary Completion Date
March 10, 2015 (Actual)
Study Completion Date
March 30, 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
University Hospital of Saint-Etienne
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Surgery plays a central role in kidney cancer management being the only therapy that offers the possibility of healing the patients. Currently, the partial nephrectomy is a standard technique because it meets the principle of nephron sparing surgery. A partial nephrectomy requires a control of the renal blood flow using a clamp, which can be parenchymal or vascular (pedicular). In France, most of the centers use pedicular clamping. It is well established that this technique results in warm ischemia of the entire healthy parenchyma and can lead to permanent kidney damages. Currently, no study evaluated the impact of parenchymal clamping on the healthy parenchyma.
The aim of the investigators study is to evaluate the nephrotoxicity of the healthy parenchyma due to parenchymal clamping during partial nephrectomy. This assessment will be done through a microdialysis technique. The microdialysis probe is directly implanted in the healthy unclamped parenchyma and will allow us to measure in real time, during the surgery, the biological changes related to anaerobic metabolism of renal interstitial space. All those measures will be completed by urinary and plasmatic assessments. Oxidative stress will be assessed using four markers of tubular viability : Interleukin 18 (IL18), Kidney Injury Molecule-1 (KIM-1), Neutrophil Gelatinase-Associated Lipocalin (NGAL) and cystatin C and four parameters of anaerobic metabolism : lactate, pyruvate, glycerol and glucose.
This is a prospective pilot study limited to 10 patients included over 12 months. Depending on the results, it will be further developed by a second study comparing parenchymal with pedicle clamping.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nephrectomy, Kidney Cancer, Microdialysis
Keywords
parenchymal clamping, microdialysis technique, partial nephrectomy
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
4 (Actual)
8. Arms, Groups, and Interventions
Arm Title
renal microdialysis
Arm Type
Other
Arm Description
patient with renal microdialysis
Intervention Type
Procedure
Intervention Name(s)
Renal microdialysis
Intervention Description
Renal microdialysis is an innovative and promising technique in the monitoring of renal ischemia. Its sterile nature enables intraoperative use to give us real-time reflection of the in situ metabolism. In Patients who participated in clinical research with this microinvasive technique, no complications including bleeding has been reported.
Primary Outcome Measure Information:
Title
Average interstitial lactate concentrations (peak lactate and lactate/pyruvate ratio)
Time Frame
every 10 minutes unitl the end of clamping
Secondary Outcome Measure Information:
Title
Interstitial concentrations of lactate, pyruvate, lactate/pyruvate ratio, glycerol concentration (marker of impaired cellular membrane) and glucose concentration
Description
composite measure
Time Frame
every 10 minutes until the end of clamping then every 300 minutes until the third hour of no-clamping
Title
Blood and urine concentration of Interleukin 18 (IL18), le Kidney Injury Molecule-1 (KIM-1), le Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin C
Description
composite measure
Time Frame
1 hour before clamping, then Hour +2, Hour +6, Hour +12, Hour +24, Hour +36 ; Hour 0 corresponding to the timing of clamping
Title
Preoperative creatinine
Time Frame
inclusion day and at 2 months postoperatively
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients referred to the urological surgery department with an indication of partial nephrectomy
Patients with a renal lesion classified T1 (≤7cm) or for T2 eligible to a partial nephrectomy and having an possibility to benefit from a parenchymal clamping (decided on preoperative imaging)
Exclusion Criteria:
Patient with a chronic kidney disease (functional or structural renal abnormality evolving for more than three months and Glomerular Filtration Rate <60 ml/min)
Patient carrying a renal lesion classified T1 but too close to the renal pedicle or not accessible for a parenchymal clamping
Patients in whom tumor removal requires ice cooling or kidney pedicular clamping
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nicolas MOTTET, MD PhD
Organizational Affiliation
CHU de Saint Etienne
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chu de Saint Etienne
City
Saint Etienne
ZIP/Postal Code
42055
Country
France
12. IPD Sharing Statement
Learn more about this trial
Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique
We'll reach out to this number within 24 hrs